Cargando…
Nanomaterial Technology and Soft Tissue Sarcomas
Soft tissue sarcomas (STSs) are relatively rare heterogeneous solid tumors of the mesenchymal origin. They account for approximately 1% of all malignant tumors in adults and have more than 70 histological subtypes. Consequently, the rarity and heterogeneity of STSs make their diagnosis and treatment...
Autores principales: | Zhou, Changkai, Chen, Xue, Huang, Ying, Zhang, Qi, Zhu, Shu, Fu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257037/ https://www.ncbi.nlm.nih.gov/pubmed/35814363 http://dx.doi.org/10.3389/fonc.2022.921983 |
Ejemplares similares
-
Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
por: Du, Xin-Hui, et al.
Publicado: (2020) -
New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023) -
Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018) -
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
por: Caruso, Chiara, et al.
Publicado: (2020) -
Targeted therapies for the treatment of soft tissue sarcoma
por: Fuchs, Jeffrey W., et al.
Publicado: (2023)